Paper
2 March 2018 Sequential neural networks for biologically informed glioma segmentation
Author Affiliations +
Abstract
In the last five years, advances in processing power and computational efficiency in graphical processing units have catalyzed dozens of deep neural network segmentation algorithms for a variety of target tissues and malignancies. However, few of these algorithms preconfigure any biological context of their chosen segmentation tissues, instead relying on the neural network’s optimizer to develop such associations de novo. We present a novel method for applying deep neural networks to the problem of glioma tissue segmentation that takes into account the structured nature of gliomas – edematous tissue surrounding mutually-exclusive regions of enhancing and non-enhancing tumor. We trained separate deep neural networks with a 3D U-Net architecture in a tree structure to create segmentations for edema, non-enhancing tumor, and enhancing tumor regions. Specifically, training was configured such that the whole tumor region including edema was predicted first, and its output segmentation was fed as input into separate models to predict enhancing and non-enhancing tumor. We trained our model on publicly available pre- and post-contrast T1 images, T2 images, and FLAIR images, and validated our trained model on patient data from an ongoing clinical trial.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Andrew Beers, Ken Chang, James Brown, Elizabeth Gerstner, Bruce Rosen, and Jayashree Kalpathy-Cramer "Sequential neural networks for biologically informed glioma segmentation", Proc. SPIE 10574, Medical Imaging 2018: Image Processing, 1057433 (2 March 2018); https://doi.org/10.1117/12.2293941
Lens.org Logo
CITATIONS
Cited by 5 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Image segmentation

Neural networks

Magnetic resonance imaging

Tissues

Brain

Clinical trials

RELATED CONTENT


Back to Top